{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-030341","form_type":"8-K","ticker":"AKTX","cik":"0001541157","company_name":"Akari Therapeutics Plc","filed_at":"2026-06-26T21:15:40+00:00","discovered_at":"2026-06-26T21:18:00.257112+00:00","generated_at":"2026-06-26T21:18:44.350644+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Akari Therapeutics consolidates remaining private placement closings, issues 980,395 ADSs","bullets":["Combined second and third closings into single closing on June 26, 2026; issued 980,395 ADSs (or prefunded warrants).","First closing of 490,193 ADSs occurred May 27, 2026, under the original three-tranche structure.","Delivery of Series H, I, and J warrants contingent on shareholder approval at June 30, 2026 annual meeting.","No other changes to the securities purchase agreement besides consolidation of closings."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-030341","json":"https://secwatch.observer/filing/0001493152-26-030341.json","markdown":"https://secwatch.observer/filing/0001493152-26-030341.md","text":"https://secwatch.observer/filing/0001493152-26-030341.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1541157/000149315226030341/0001493152-26-030341-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1541157/000149315226030341/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T21:18:44.350644+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}